OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effectiveness of Tocilizumab in Patients with Severe or Critical Lung Involvement in COVID-19: A Retrospective Study
Daniel Chober, Bogusz Aksak‐Wąs, Katarzyna Bobrek‐Lesiakowska, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 9, pp. 2286-2286
Open Access | Times Cited: 7
Daniel Chober, Bogusz Aksak‐Wąs, Katarzyna Bobrek‐Lesiakowska, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 9, pp. 2286-2286
Open Access | Times Cited: 7
Showing 7 citing articles:
Clinical Consequences for Individuals Treated with Tocilizumab for Serious COVID-19 Infection
Al Shaimaa Ibrahim Rabie, Hager Salah, Amira S. A. Said, et al.
Healthcare (2023) Vol. 11, Iss. 4, pp. 607-607
Open Access | Times Cited: 8
Al Shaimaa Ibrahim Rabie, Hager Salah, Amira S. A. Said, et al.
Healthcare (2023) Vol. 11, Iss. 4, pp. 607-607
Open Access | Times Cited: 8
Artificial neural network based prediction of the lung tissue involvement as an independent in‐hospital mortality and mechanical ventilation risk factor in COVID‐19
Miłosz Parczewski, Jakub Kufel, Bogusz Aksak‐Wąs, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 5
Closed Access | Times Cited: 7
Miłosz Parczewski, Jakub Kufel, Bogusz Aksak‐Wąs, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 5
Closed Access | Times Cited: 7
Application of Machine Learning in Hospitalized Patients with Severe COVID-19 Treated with Tocilizumab
Antonio Ramón, Marta Zaragozá, Ana María Torres, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 16, pp. 4729-4729
Open Access | Times Cited: 6
Antonio Ramón, Marta Zaragozá, Ana María Torres, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 16, pp. 4729-4729
Open Access | Times Cited: 6
Remdesivir Reduces Mortality in Hemato-Oncology Patients with COVID-19
Bogusz Aksak‐Wąs, Daniel Chober, Karol Serwin, et al.
Journal of Inflammation Research (2022) Vol. Volume 15, pp. 4907-4920
Open Access | Times Cited: 6
Bogusz Aksak‐Wąs, Daniel Chober, Karol Serwin, et al.
Journal of Inflammation Research (2022) Vol. Volume 15, pp. 4907-4920
Open Access | Times Cited: 6
Improved survival in intensive care unit in severe COVID-19 associated with amantadine use - retrospective study
Daniel Chober, Z Czajkowski, Bogusz Aksak‐Wąs, et al.
International Journal of Infectious Diseases (2022) Vol. 124, pp. 143-151
Open Access | Times Cited: 5
Daniel Chober, Z Czajkowski, Bogusz Aksak‐Wąs, et al.
International Journal of Infectious Diseases (2022) Vol. 124, pp. 143-151
Open Access | Times Cited: 5
Tocilizumab Use among Patients Who Developed Pulmonary Embolism in the Course of Cytokine Release Storm and COVID-19 Pneumonia—A Retrospective Study
Daniel Chober, Bogusz Aksak‐Wąs, Jolanta Niścigórska-Olsen, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1581-1581
Open Access | Times Cited: 3
Daniel Chober, Bogusz Aksak‐Wąs, Jolanta Niścigórska-Olsen, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1581-1581
Open Access | Times Cited: 3
A reduced fixed dose of Tocilizumab 200 mg compared to 400 mg in patients with severe COVID-19 disease
Stela Cojocaru, Ірина Руссу, Galina Buta, et al.
One Health & Risk Management (2023) Vol. 4, Iss. 4
Open Access
Stela Cojocaru, Ірина Руссу, Galina Buta, et al.
One Health & Risk Management (2023) Vol. 4, Iss. 4
Open Access
